The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumor genomics and response to CDK 4/6 inhibitors for patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC).
 
Laura Spring
No Relationships to Disclose
 
Andrzej Niemierko
No Relationships to Disclose
 
Dejan Juric
Consulting or Advisory Role - Eisai; EMD Serono; Novartis
 
Mark Zangardi
No Relationships to Disclose
 
Elizabeth Abraham
No Relationships to Disclose
 
Dora Dias-Santagata
No Relationships to Disclose
 
Leif W. Ellisen
Honoraria - Invitae
Consulting or Advisory Role - Vertex
Travel, Accommodations, Expenses - Invitae
 
Steven J. Isakoff
Consulting or Advisory Role - Abbvie; Merrimack; Myriad Genetics; PharmaMar
Research Funding - Abbvie; Genentech; OncoPep; PharmaMar
Travel, Accommodations, Expenses - Myriad Genetics
 
A. John Iafrate
Stock and Other Ownership Interests - Archer
Consulting or Advisory Role - Chugai Pharma; Constellation Pharmaceuticals; Debiopharm Group
Research Funding - Blueprint Medicines
Patents, Royalties, Other Intellectual Property - ArcherDx exclusive license to AMP technology
 
Beverly Moy
Consulting or Advisory Role - MOTUS (I)
 
Aditya Bardia
Consulting or Advisory Role - Genentech; Novartis